info icon

Other congenital malformations of posterior segment of eye (coloboma)

Q17_CONGEN_MALFO_OTHERPOSTER

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 Q14.8
  • Cause of death: ICD-10 Q14.8

2 out of 7 registries used, show all original rules.

33

4. Check minimum number of events

None

33

5. Include endpoints

None

33

6. Filter based on genotype QC (FinnGen only)

33

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF6v3

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 638 342 295
Only index persons 516 282 234
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 9.01 8.91 8.97
Only index persons 16.04 17.08 14.78

-FinnGen-

Key figures

All Female Male
Number of individuals 33 18 15
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 38.27 44.39 30.92

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
19
101
3.08
2.49
2.6
2.4
nmol/l
82.6
75.2
0.71
19
92
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
11
48
2.94
1.96
3.5
3.2
ng/l
577.6
2317.7
0.65
11
41
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
14
77
2.42
1.56
1.5
1.5
pmol/l
90.4
92.7
—
5
38
(3018677) aPTT in Platelet poor plasma by Coagulation assay
8
39
2.38
1.26
1.1
5.6
s
29.6
30.4
—
8
39
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
35
0.00
1.24
0.0
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
0
35
0.00
1.24
0.0
1.3
—
1.5
—
0
29
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
10
52
2.32
1.22
1.5
2.4
u/l
235.8
280.3
—
10
52
(3021960) Folate [Moles/volume] in Serum or Plasma
9
45
2.37
1.17
1.7
1.2
nmol/l
28.2
23.5
—
9
40
(40758558) Short blood count panel - Blood
13
77
2.14
1.17
3.5
7.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5
98
0.42
0.98
1.4
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
31
2.14
0.89
1.2
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
9
139
0.52
0.87
2.2
3.1
—
0.0
—
0
27
(3013512) EKG study
9
55
1.87
0.83
4.2
3.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
16
115
1.76
0.76
3.8
2.8
ug/l
50.7
89.8
1.80
16
104
(36660697) Celiac disease serology panel - Serum
5
26
2.08
0.74
1.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
6
34
1.93
0.63
7.5
8.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
20
0.00
0.62
0.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
0
19
0.00
0.62
0.0
1.3
—
—
—
0
0
(3015736) pH of Urine
7
104
0.59
0.62
1.9
2.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
6
36
1.81
0.61
1.2
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
14
103
1.62
0.58
3.6
12.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
38
1.70
0.58
2.0
2.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
6
93
0.57
0.52
2.2
4.8
u/l
20.2
32.0
—
6
88
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
7
50
1.51
0.49
3.9
4.5
ug/l
1.8
1.6
—
7
45
(3018418) pH of Serum or Plasma
9
67
1.47
0.43
3.6
3.4
—
7.4
—
0
14
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
0
18
0.00
0.41
0.0
9.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
5
36
1.46
0.40
3.0
13.9
kpa
7.0
4.9
—
5
36
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
42
1.52
0.38
2.3
2.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
14
114
1.40
0.32
2.6
6.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
10
77
1.43
0.30
1.6
1.7
g/l
1.5
2.1
—
5
39
(3037467) Urinalysis macro (dipstick) panel - Urine
21
186
1.35
0.27
3.8
3.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
5
37
1.41
0.25
3.0
13.6
kpa
5.6
5.8
—
5
37
(3044889) 12 lead EKG panel
18
158
1.31
0.23
2.3
3.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
11
0.00
0.22
0.0
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
11
0.00
0.22
0.0
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
0
11
0.00
0.22
0.0
2.3
—
0.1
—
0
11
(3025941) Bacteria identified in Stool by Culture
0
11
0.00
0.22
0.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
10
0.00
0.22
0.0
49.6
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
0
10
0.00
0.22
0.0
2.3
—
7.6
—
0
10
(3013290) Carbon dioxide [Partial pressure] in Blood
0
10
0.00
0.22
0.0
2.3
—
4.8
—
0
10
(3020891) Body temperature
0
12
0.00
0.21
0.0
3.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(4094501)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
6
51
1.21
0.21
2.5
5.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
8
69
1.21
0.18
1.8
2.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
6
78
0.72
0.18
1.8
1.8
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
9
77
1.23
0.18
2.2
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
21
192
1.26
0.17
2.7
4.3
mm/h
7.1
10.1
1.42
21
182
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
8
94
0.80
0.16
3.0
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
10
85
1.25
0.14
1.7
3.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
13
115
1.22
0.13
12.5
13.9
mmol/l
1.2
1.2
0.47
13
102
(3026008) Bacteria identified in Urine by Culture
6
57
1.06
0.09
1.5
2.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
5
63
0.76
0.09
1.4
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
7
65
1.10
0.09
2.3
2.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
7
79
0.86
0.08
1.4
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
9
83
1.12
0.08
1.4
1.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
19
179
1.14
0.07
2.8
3.9
u/l
33.2
38.4
0.35
19
173
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
23
239
0.88
0.05
4.8
3.6
mmol/l
5.5
5.8
1.47
23
219
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
23
223
1.10
0.02
3.3
3.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
15
148
1.02
0.00
3.5
13.8
e9/l
0.0
0.0
—
10
108
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
0
6
0.00
0.00
0.0
81.7
—
1.5
—
0
6
(3038515) Glucose [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.7
—
7.8
—
0
6
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.2
—
36.1
—
0
9
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
6
0.00
0.00
0.0
6.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
7.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
9
0.00
0.00
0.0
10.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
9
0.00
0.00
0.0
8.9
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
6
0.00
0.00
0.0
1.7
—
1.6
—
0
6
(3034770) Mitochondria Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
0
9
0.00
0.00
0.0
1.0
—
5.7
—
0
9
(3007930) Methemoglobin/Hemoglobin.total in Blood
0
6
0.00
0.00
0.0
81.7
—
0.7
—
0
6
(3039443) Prostate specific Ag panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
8
0.00
0.00
0.0
2.0
—
216.5
—
0
8
(3019832) Treponema pallidum Ab [Presence] in Serum
5
50
1.00
0.00
1.2
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
17.6
—
0
5
(1761482) Bacteria [#/volume] in Urine by Culture
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
7.2
—
0
5
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
10
100
1.00
0.00
2.2
3.1
e6/l
3.0
48.2
—
5
58
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
0.5
—
0
5
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
11.5
—
0
5
(3021706) Oxygen [Partial pressure] in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
3.5
—
0
5
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
6
65
0.91
0.00
3.8
5.1
umol/l
371.7
315.6
—
6
60
(3049717) Cytology report of Urine Cyto stain
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
0.2
—
0
7
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
5
52
0.95
0.00
2.4
2.6
mg/l
2.5
2.4
—
5
45
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
10.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
16.2
—
0.7
—
0
5
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8
86
0.91
0.00
1.3
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
1.2
—
0
7
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint Q17_CONGEN_MALFO_OTHERPOSTER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_MALFO_OTHERPOSTER.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: Q17_CONGEN_MALFO_OTHERPOSTER – Other congenital malformations of posterior segment of eye (coloboma)

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data